
The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs — but not everyone will qualify.
Source link
add a comment

The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs — but not everyone will qualify.
Source link
Get our latest downloads and information first.
Complete the form below to subscribe to our weekly newsletter.